Malignant melanoma of the uveal tract is a rare malignancy but a significant cause of mortality and visual loss. Approximately 50% of patients diagnosed with a melanoma of the choroid or ciliary body will die of the disease within 15 years of enucleation.
Methods
The author reviewed the current literature on the clinical findings, epidemiology, and treatment of uveal melanoma.
Results
Methods of diagnosis have improved substantially in the past several years, although clinical diagnosis by an experienced examiner remains the standard in eyes with clear media. Ultrasound is the most useful adjunctive technique. While enucleation has been the mainstay of therapeutic intervention, alternative therapies – especially different types of irradiation – offer hope for tumor control and vision preservation. The Collaborative Ocular Melanoma Study, a multicenter national trial, is designed to provide long-term data on the natural history as well as therapeutic intervention.
Conclusions
Malignant melanoma of the uveal tract can be diagnosed clinically with more confidence than ever before. It is also possible in many cases to retain the eye and functional vision while controlling the tumor. However, unanswered questions remain about the natural history and optimal therapy of uveal melanoma.
Get full access to this article
View all access options for this article.
References
1.
MargoC.E., McLeanI.W.Malignant melanoma of the choroid and ciliary body in black patients. Arch Ophthalmol.1984; 102: 77–79.
2.
WellsC.G., BradfordR.H., FishG.E.COMS Group. Choroidal melanomas in American Indians. Arch Ophthalmol.1996; 114: 1017–1018.
EganK.M., RyanL.M., GragoudasE.S.Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: an example of regression on time-dependent covariates. Arch Ophthalmol.1998; 116: 366–370.
5.
GeisseL.J., RobertsonD.M.Iris melanomas. Am J Ophthalmol.1985; 99: 638–648.
6.
SeddonJ.M., GragoudasE.S., GlynnR.J.Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol.1990; 108: 1274–1280.
7.
ShieldsC.L., ShieldsJ.A., MiliteJ.Uveal melanoma in teenagers and children. A report of 40 cases. Ophthalmology.1991; 98: 1662–1666.
8.
BarrC.C., McLeanI.W., ZimmermanL.E.Uveal melanoma in children and adolescents. Arch Ophthalmol.1981; 99: 2133–2136.
9.
JohnsonM.W., SkutaG.L., KincaidM.C.Malignant melanoma of the iris in xeroderma pigmentosum. Arch Ophthalmol.1989; 107: 402–407.
10.
SinghA.D., De PotterP., FijalB.A.Lifetime prevalence of uveal melanoma in white patients with oculo (dermal) melanocytosis. Ophthalmology.1998; 105: 195–198.
11.
ShieldsC.L., ShieldsJ.A., EagleR.C.Jr. Uveal melanoma and pregnancy. A report of 16 cases. Ophthalmology.1991; 98: 1667–1673.
12.
FossA.J., AlexanderR.A., GuilleM.J.Estrogen and progesterone receptor analysis in ocular melanomas. Ophthalmology.1995; 102: 431–435.
13.
SinghA.D., ShieldsC.L., ShieldsJ.A.Bilateral primary uveal melanoma. Bad luck or bad genes?Ophthalmology.1996; 103: 256–262.
14.
SinghA.D., WangM.X., DonosoL.A.Familial uveal melanoma, III. Is the occurrence of familial uveal melanoma coincidental?Arch Ophthalmol.1996; 114: 1101–1104.
15.
JakobiecF.A., SilbertG.Are most iris “melanomas” really nevi? A clinicopathologic study of 189 lesions. Arch Ophthalmol.1981; 99: 2117–2132.
16.
CharD.H., StoneR.D., IrvineA.R.Diagnostic modalities in choroidal melanoma. Am J Ophthalmol.1980; 89: 223–230.
17.
FontR.L., ZimmermanL.E., ArmalyM.F.The nature of the orange pigment over a choroidal melanoma. Histochemical and electron microscopical observations. Arch Ophthalmol.1974; 91: 359–362.
18.
CunliffeI.A., RennieI.G.Choroidal melanoma presenting as vitreous haemorrhage. Eye.1993; 7: 711–713.
19.
el BabaF., HaglerW.S., De la CruzA.Choroidal melanoma with pigment dispersion in vitreous and melanomalytic glaucoma. Ophthalmology.1988; 95: 370–377.
FontR.L., SpauldingA.G., ZimmermanL.E.Diffuse malignant melanoma of the uveal tract. A clinicopathologic report of 54 cases. Trans Am Acad Ophthalmol Otolaryngol.1968; 72: 877–895.
23.
RosenbaumP.S., BoniukM., FontR.L.Diffuse uveal melanoma in a 5-year-old child. Am J Ophthalmol.1988; 106: 601–606.
24.
VölckerH.E., NaumannG.O.Multicentric primary malignant melanomas of the choroid: two separate malignant melanomas of the choroid and two uveal naevi in one eye. Br J Ophthalmol.1978; 62: 408–413.
25.
BarrC.C., ZimmermanL.E., CurtinV.T.Bilateral diffuse melanocytic uveal tumors associated with systemic malignant neoplasms: a recently recognized syndrome. Arch Ophthalmol.1982; 100: 249–255.
26.
CharD.H., CrawfordJ.B., CastroJ.R.Failure of choroidal melanoma to respond to helium ion therapy. Arch Ophthalmol.1983; 101: 236–241.
27.
KincaidM.C., FolbergR., TorczynskiE.Complications after proton beam therapy for uveal malignant melanoma. A clinical and histopathologic study of five cases. Ophthalmology.1988; 95: 982–991.
28.
YanoffM.Glaucoma mechanisms in ocular malignant melanomas. Am J Ophthalmol.1970; 70: 898–904.
29.
MartinJ.A., RobertsonD.M.Extrascleral extension of choroidal melanoma diagnosed by ultrasound. Ophthalmology.1983; 90: 1554–1559.
ShieldsJ.A., AugsburgerJ.J.Cataract surgery and intraocular lenses in patients with unsuspected malignant melanoma of the ciliary body and choroid. Ophthalmology.1985; 92: 823–826.
32.
AugsburgerJ.J., GoldenM.I., ShieldsJ.A.Fluorescein angiography of choroidal malignant melanomas with retinal invasion. Retina.1984; 4: 232–241.
33.
MuellerA.J., BartschD.U., FolbergR.Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy. Arch Ophthalmol.1998; 116: 31–39.
34.
BloomP.A., FerrisJ.D., LaidlawD.A.Magnetic resonance imaging. Diverse appearances of uveal malignant melanomas. Arch Ophthalmol.1992; 110: 1105–1111.
35.
CharD.H., MillerT.R., CrawfordJ.B.Cytopathologic diagnosis of benign lesions simulating choroidal melanomas. Am J Ophthalmol.1991; 112: 70–75.
36.
AugsburgerJ.J., ShieldsJ.A., FolbergR.Fine needle aspiration biopsy in the diagnosis of intraocular cancer: cytologic-histologic correlations. Ophthalmology.1985; 92: 39–49.
37.
CharD.H., KrollS.M., MillerT.Irradiated uveal melanomas: cytopathologic correlation with prognosis. Am J Ophthalmol.1996; 122: 509–513.
38.
FolbergR., RummeltV., Parys-Van GinderdeurenR.The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology.1993; 100: 1389–1398.
39.
GragoudasE.S., EganK.M., SeddonJ.M.Survival of patients with metastases from uveal melanoma. Ophthalmology.1991; 98: 383–389.
40.
CharD.H.Metastatic choroidal melanoma. Am J Ophthalmol.1978; 86: 76–80.
41.
AlbertD.M.The ocular melanoma story. LIII Edward Jackson Memorial Lecture. Part II. Am J Ophthalmol.1997; 123: 729–741.
The Collaborative Ocular Melanoma Study Group.Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS Report No. 1. Arch Ophthalmol.1990; 108: 1268–1273.
44.
MargoC.E.The accuracy of diagnosis of posterior uveal melanoma. Arch Ophthalmol.1997; 115: 432–434.
45.
McLeanI.W., ZimmermanL.E., EvansR.M.Reappraisal of Callender's spindle a type of malignant melanoma of choroid and ciliary body. Am J Ophthalmol.1978; 86: 557–564.
46.
HeitmanK.F., KincaidM.C., SteahlyL.Diffuse malignant change in a ciliochoroidal melanocytoma in a patient of mixed racial background. Retina.1988; 8: 67–72.
47.
FerryA.P., FontR.L.Carcinoma metastatic to the eye and orbit. I. A clinicopathologic study of 227 cases. Arch Ophthalmol.1974; 92: 276–286.
48.
AlbertD.M., RubensteinR.A., ScheieH.G.Tumor metastasis to the eye. I. Incidence in 213 adult patients with generalized malignancy. Am J Ophthalmol.1967; 63: 723–726.
49.
YeoJ.H., JakobiecF.A., IwamotoT.Metastatic carcinoma masquerading as scleritis. Ophthalmology.1983; 90: 184–194.
50.
MorganWE3rd, MalmgrenR.A., AlbertD.M.Metastatic carcinoma of the ciliary body simulating uveitis. Diagnosis by cytologic examination of aqueous humor. Arch Ophthalmol.1970; 83: 54–58.
51.
PiroP., PappasH.R., ErozanY.S.Diagnostic vitrectomy in metastatic breast carcinoma in the vitreous. Retina.1982; 2: 182–188.
52.
ScholzR., GreenW.R., BarananoE.C.Metastatic carcinoma to the iris. Diagnosis by aqueous paracentesis and response to irradiation and chemotherapy. Ophthalmology.1983; 90: 1524–1527.
53.
ShieldsJ.A., StephensR.F., EagleR.C.Jr. Progressive enlargement of a circumscribed choroidal hemangioma. Arch Ophthalmol.1992; 110: 1276–1278.
54.
SpraulC.W., KimD., FinebergE.Mushroom-shaped choroidal hemangioma. Am J Ophthalmol.1996; 122: 434–436.
55.
TrimbleS.N., SchatzH., SchneiderG.B.Spontaneous decalcification of a choroidal osteoma. Ophthalmology.1988; 95: 631–634.
56.
KatzR.S., GassJ.D.Multiple choroidal osteomas developing in association with recurrent orbital inflammatory pseudotumor. Arch Ophthalmol.1983; 101: 1724–1727.
57.
CallenderG.R.Malignant melanotic tumors of the eye: a study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol.1931; 36: 131–142.
58.
McLeanI.W., FosterW.D., ZimmermanL.E.Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol.1983; 96: 502–509.
59.
GamelJ.W., McLeanI.W.Quantitative analysis of the Callender classification of uveal melanoma cells. Arch Ophthalmol.1977; 95: 686–691.
60.
GrossniklausH.E., OakmanJ.H., CohenC.Histopathology, morphometry, and nuclear DNA content of iris melanocytic lesions. Invest Ophthalmol Vis Sci.1995; 36: 745–750.
61.
Pe'erJ., RummeltV., MawnL.Mean of the ten largest nucleoli, microcirculation architecture, and prognosis of ciliochoroidal melanomas. Ophthalmology.1994; 101: 1227–1235.
62.
MehaffeyM.G., FolbergR., MeyerM.Relative importance of quantifying area and vascular patterns in uveal melanoma. Am J Ophthalmol.1997; 123: 798–809.
63.
McLeanI.W., KeefeK.S., BurnierM.N.Uveal melanoma. Comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type, and tumor size. Ophthalmology.1997; 104: 777–780.
64.
MarcusD.M., MinkovitzJ.B., WardwellS.D.The Collaborative Ocular Melanoma Study Group. The value of nucleolar organizer regions in uveal melanoma. Am J Ophthalmol.1990; 110: 527–534.
65.
ZimmermanL.E., McLeanI.W., FosterW.D.Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells?Br J Ophthalmol.1978; 62: 420–425.
66.
SeigelD., MyersM., FerrisF3rd. Survival rates after enucleation of eyes with malignant melanoma. Am J Ophthalmol.1979; 87: 761–765.
67.
FingerP.T.Radiation therapy for choroidal melanoma. Surv Ophthalmol.1997; 42: 215–232.
68.
SeddonJ.M., GragoudasE.S., EganK.M.Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology.1990; 97: 769–777.
69.
PackerS.Iodine-125 radiation of posterior uveal melanoma. Ophthalmology.1987; 94: 1621–1626.
70.
SaornilM.A., FisherM.R., CampbellR.J.Histopathologic study of eyes after I 125 episcleral plaque irradiation for uveal melanoma. Arch Ophthalmol.1997; 115: 1395–1400.
71.
OosterhuisJ.A., Journäe-de KorverH.G.Transpupillary thermotherapy: results in 50 patients with choroidal melanoma. Arch Ophthalmol.1998; 116: 157–162.
72.
FingerP.T.Microwave thermoradiotherapy for uveal melanoma: results of a 10-year study. Ophthalmology.1997; 104: 1794–1803.
73.
ShieldsC.L., ShieldsJ.A., CaterJ.Transpupillary thermotherapy for choroidal melanoma: tumor control and visual results in 100 consecutive cases. Ophthalmology.1998; 105: 581–590.
74.
SaornilM.A., EganK.M., GragoudasE.S.Histopathology of proton beam-irradiated vs enucleated uveal melanomas. Arch Ophthalmol.1992; 110: 1112–1118.
75.
KimM.K., CharD.H., CastroJ.L.Neovascular glaucoma after helium ion irradiation for uveal melanoma. Ophthalmology.1986; 93: 189–193.
76.
CharD.H., KrollS.M., CastroJ.Ten-year follow-up of helium ion therapy for uveal melanoma. Am J Ophthalmol.1998; 125: 81–89.
77.
AppleD.J., GoldbergM.F., WyhinnyG.Argon laser photocoagulation of choroidal malignant melanoma. Tissue effects after a single treatment. Arch Ophthalmol.1973; 90: 97–101.
78.
BarrC.C., NortonE.W.Recurrence of choroidal melanoma after photocoagulation therapy. Arch Ophthalmol.1983; 101: 1737–1740.
79.
ShieldsJ.A., ShieldsC.L., ShahP.Partial lamellar sclerouvectomy for ciliary body and choroidal tumors. Ophthalmology.1991; 98: 971–983.
80.
RobertsonD.M., CampbellR.J., WeaverD.T.Residual intrascleral and intraretinal melanoma: a concern with lamellar sclerouvectomy for uveal melanoma. Am J Ophthalmol.1991; 112: 590–593.
81.
StraatsmaB.R., FineS.L., EarleJ.D.Enucleation versus plaque irradiation for choroidal melanoma. Ophthalmology.1988; 95: 1000–1004.
82.
Collaborative Ocular Melanoma Study Group.Histopathologic characteristics of uveal melanomas in eyes enucleated from the Collaborative Ocular Melanoma Study: COMS Report No. 6. Am J Ophthalmol.1998; 125: 745–766.
83.
Collaborative Ocular Melanoma Study Group.The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS Report No. 10. Am J Ophthalmol.1998; 125: 779–796.
